HengRui USA

HengRui USA is an emerging biotechnology company focused on delivering innovative medicines to more patients worldwide. Through an unprecedented partnership with our parent company, HengRui USA team members are actively co-developing multiple drug candidates in areas of high unmet medical need.

Learn more

Jiangsu Hengrui Pharmaceuticals

Jiangsu Hengrui Pharmaceuticals is a global pharmaceutical company engaged in the research, development, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, surgical drugs, contrast agents and antibiotics. The company was established in 1970 and is headquartered in Lianyungang, Jiangsu. It was listed on the Shanghai Stock Exchange in 2000. It is also the largest listed pharmaceutical company in China. As of the end of 2019, it had more than 24,400 employees worldwide.